Govt Medical College Staffers, Chemist Arrested For Remdesivir Black Marketing In MP
- byDoctor News Daily Team
- 11 July, 2025
- 0 Comments
- 0 Mins
Shahdol: Three employees of a government medical college and a chemist were arrested for alleged black marketing of Remdesivir injections, used in the treatment of COVID-19, in Madhya Pradesh's Shahdol district, police said on Wednesday.
Following the arrest, the Shahdol Government Medical College administration terminated the services of the three accused staffers, an official said.
Also Read:Ayurveda Doctor, nurse among 6 arrested for Remdesivir black marketing in Delhi
Based on a tip-off, the police on Tuesday nabbed a lab technician, a lab assistant and a nurse of the Government Medical College and a drug store owner, additional superintendent of police Mukesh Vaishy said.
The accused were identified as lab assistant Deepak Gupta (23), technician Ujwal Dwivedi (30), staff nurse Sushma Sahu (28) and Amit Mishra (33), a drug store owner, he said.
The police seized six Remdesivir injections, five mobile phones and Rs 6.49 lakh cash from the accused, Vaishy said.
The accused were allegedly selling the anti-viral injection, meant for patients at the government medical college, to others at a higher price, he said.
The accused have been booked under the relevant provisions of the Indian Penal Code, Madhya Pradesh Drug Control Act and Essential Commodities Act, the official said.
Shahdol's divisional commissioner Rajeev Sharma said services of Dwivedi and Sahu, both employed under the National Health Mission, and Gupta (an outsource employee) have been terminated with immediate effect.
A letter will be sent to the Madhya Pradesh Nursing Council directing them to cancel the registration of the accused nurse, who was working in the COVID-19 care ward, he said.
Similarly, a letter will also be written to the Madhya Pradesh Paramedical Council asking them to cancel the registration of the accused lab technician and lab assistant, the official added.
Also Read:Maha Health Minister says Pharma firms not supplying mandated Remdesivir quota
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
Recent News
Pfizer files lawsuit against Metsera, its Director...
- 02 November, 2025
Health Ministry achieves 3 Guinness World Records...
- 02 November, 2025
Roche gets CE mark for Elecsys Dengue Ag test to d...
- 02 November, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.
0 Comments
Post a comment
No comments yet. Be the first to comment!